Eganelisib
2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
Molecular Identity
Eganelisib
2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
PubChem CID: 91933883
2D Structure
Properties
C30H24N8O2
Molecular Formula
528.60
Molecular Weight
g/mol
528.2022
Exact Mass
Da
3.2
XLogP
Drug-like (Lipinski: < 5)
123
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
6
H-Bond Acceptors
1060
Complexity
SMILES
Canonical SMILES
SMILES: CC(C1=CC2=C(C(=CC=C2)C#CC3=CN(N=C3)C)C(=O)N1C4=CC=CC=C4)NC(=O)C5=C6N=CC=CN6N=C5NIsomeric SMILES
SMILES: C[C@@H](C1=CC2=C(C(=CC=C2)C#CC3=CN(N=C3)C)C(=O)N1C4=CC=CC=C4)NC(=O)C5=C6N=CC=CN6N=C5NSynonyms(20)
IPI-5491693758-51-8Eganelisibpi3k-gamma Inhibitor IPI-549FOF5155FMZ(S)-2-amino-N-(1-(8-((1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-1,2-dihydroisoquinolin-3-yl)ethyl)pyrazolo[1,5-a]pyrimidine-3-carboxamideDTXSID3013365802-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamidePyrazolo(1,5-a)pyrimidine-3-carboxamide, 2-amino-N-((1S)-1-(1,2-dihydro-8-(2-(1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-3-isoquinolinyl)ethyl)-Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 2-amino-N-[(1S)-1-[1,2-dihydro-8-[2-(1-methyl-1H-pyrazol-4-yl)ethynyl]-1-oxo-2-phenyl-3-isoquinolinyl]ethyl]-IPI 549(S)-2-AMINO-N-(1-(8-((1-METHYL-1H-PYRAZOL-4-YL)ETHYNYL)-1-OXO-2-PHENYL-1,2-DIHYDROISOQUINOLIN-3-YL)ETHYL)PYRAZOLO(1,5-A)PYRIMIDINE-3-CARBOXAMIDE2-amino-N-((1S)-1-(8-(2-(1-methylpyrazol-4-yl)ethynyl)-1-oxo-2-phenylisoquinolin-3-yl)ethyl)pyrazolo(1,5-a)pyrimidine-3-carboxamideRefChem:136348DTXCID301766789
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Eganelisib
Loading drug network...